Saki Yamamoto

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

Toshiyuki Hayashi, Tomoyasu Fukui, Noriko Nakanishi et al. · Cardiovascular Diabetology · 2017 · 200 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes

Makoto Ohara, Tomoyasu Fukui, Motoshi Ouchi et al. · Diabetes Research and Clinical Practice · 2016 · 107 citations · Full text

Medicine, Endocrinology, Diabetology +16

Analysis of pancreatic volume in acute‐onset, slowly‐progressive and fulminant type 1 diabetes in a Japanese population

Hiroto Sasamori, Tomoyasu Fukui, Toshiyuki Hayashi et al. · Journal of Diabetes Investigation · 2018 · 31 citations · Full text

Medicine, Endocrinology, Internal Medicine +15

Association of red blood cell and platelet transfusions with persistent inflammation, immunosuppression, and catabolism syndrome in critically ill patients

Ginga Suzuki, Ryo Ichibayashi, Yuka Masuyama et al. · Scientific Reports · 2022 · 22 citations · Full text

Medicine, Hematology, Internal Medicine +17

Clinical significance of urinary L-FABP in the emergency department

Ginga Suzuki, Ryo Ichibayashi, Saki Yamamoto et al. · International Journal of Emergency Medicine · 2019 · 21 citations · Full text

Medicine, Emergency Medicine, Nephrology +16